霉酚酸酯（ｍｙｃｏｐｈｅｎｏｌａｔｅｍｏｆｅｔｉｌ）是美国食品药品管理局（ＦＤＡ）于１９９８年１０月批准上市的具免疫抑制作用的抗生素［１］，主要用于肾脏及心脏移植术后器官排斥的预防，并能与环孢霉素合用，降低后者的剂量和毒性。结构式如下。１药效学霉酚酸... Mycophenolate mofetil is an immunosuppressive antibiotic approved by the U.S. Food and Drug Administration (FDA) in October 1998 [1] and is mainly used for the prevention of organ rejection after kidney and heart transplantation In combination with cyclosporin, the dose and toxicity of the latter are reduced. Structure is as follows. 1 pharmacodynamics mycophenolic acid ...